--- title: "Kanzhun Details March–April 2026 Buybacks With No Change in Total Issued Shares" type: "News" locale: "en" url: "https://longbridge.com/en/news/284011713.md" description: "Kanzhun Ltd announced that its issued share capital remained unchanged at 840,416,267 Class A ordinary shares as of April 23, 2026. The company conducted on-market share repurchases between March 20 and April 23, 2026, at prices ranging from US$6.55 to US$7.25 per share, aimed at enhancing shareholder value. The latest analyst rating for Kanzhun (BZ) is a Buy with a price target of $19.00, reflecting strong financial performance despite some bearish technical indicators. Kanzhun operates as an equity issuer listed on the Hong Kong Stock Exchange under stock code 2076." datetime: "2026-04-24T13:13:59.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/284011713.md) - [en](https://longbridge.com/en/news/284011713.md) - [zh-HK](https://longbridge.com/zh-HK/news/284011713.md) --- # Kanzhun Details March–April 2026 Buybacks With No Change in Total Issued Shares ### Claim 30% Off TipRanks - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks The latest announcement is out from Kanzhun Ltd Sponsored ( (BZ) ). Kanzhun Limited reported in an April 24, 2026 filing that its issued share capital remained unchanged at 840,416,267 Class A ordinary shares between April 22 and April 23, 2026, with no treasury shares outstanding. As of April 23, 2026, the company also had 710,836 Class A ordinary shares issued to its depositary for future ADS issuances under its share incentive plans, indicating ongoing use of equity-based compensation without immediate dilution of the total issued share count. In a detailed Next Day Disclosure Return to the Hong Kong Stock Exchange dated April 24, 2026, Kanzhun disclosed a series of on-market share repurchases for cancellation conducted between March 20 and April 23, 2026 at prices mostly between about US$6.55 and US$7.25 per share. These buybacks, which cumulatively represent small percentage reductions on individual trading days and are pending cancellation, signal continued capital management aimed at enhancing shareholder value while gradually tightening the company’s free float. The most recent analyst rating on (BZ) stock is a Buy with a $19.00 price target. To see the full list of analyst forecasts on Kanzhun Ltd Sponsored stock, see the BZ Stock Forecast page. **Spark’s Take on BZ Stock** According to Spark, TipRanks’ AI Analyst, BZ is a Outperform. Kanzhun Ltd’s strong financial performance and positive earnings call sentiment are the primary drivers of its high score. The company’s robust revenue and profit growth, coupled with successful AI integration, position it well for future growth. However, the technical indicators suggest a bearish trend, and the valuation is moderate, which slightly tempers the overall score. To see Spark’s full report on BZ stock, click here. **More about Kanzhun Ltd Sponsored** Kanzhun Limited, incorporated in the Cayman Islands and headquartered in Beijing, operates as an equity issuer with weighted voting rights and Class A ordinary shares listed on the Hong Kong Stock Exchange under stock code 2076. The company is a foreign private issuer in the United States, reporting to the SEC under Form 20-F, which positions it within the global capital markets and subjects it to multi-jurisdictional regulatory oversight. **Average Trading Volume:** 4,155,607 **Technical Sentiment Signal:** Sell **Current Market Cap:** $6.56B For an in-depth examination of BZ stock, go to TipRanks’ Overview page. ### Related Stocks - [BZ.US](https://longbridge.com/en/quote/BZ.US.md) - [02076.HK](https://longbridge.com/en/quote/02076.HK.md) ## Related News & Research - [Kanzhun files HKEX return disclosing share repurchase at USD 7.14 per share](https://longbridge.com/en/news/285858412.md) - [BOSS Zhipin's Sustained Share Repurchases Achieved Nearly RMB880 Million in 2026 | BZ Stock News](https://longbridge.com/en/news/282983108.md) - [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md) - [Acenta Group delays Q1 interim report release to May 29, 2026](https://longbridge.com/en/news/287031560.md) - [Correction: NextNRG to Host First Quarter 2026 Financial Results Conference Call on May 18, 2026 at 9:00 a.m. ET | NXXT Stock News](https://longbridge.com/en/news/286673001.md)